Dermata Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. 

CEO
Gerald T. Proehl
CEOGerald T. Proehl
Employees
8
Employees8
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
8
Employees8

DRMA Key Statistics

Market cap
5.25M
Market cap5.25M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
176.03K
Average volume176.03K
High today
$0.55
High today$0.55
Low today
$0.5201
Low today$0.5201
Open price
$0.5201
Open price$0.5201
Volume
46.77K
Volume46.77K
52 Week high
$6.95
52 Week high$6.95
52 Week low
$0.435
52 Week low$0.435

DRMA Earnings

-$0.86
-$0.57
-$0.29
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14
ActualExpected Nov 14
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.